Silvia Buonamici
PhD
Vice President and Head of Cancer Biology
👥Biography 个人简介
Silvia Buonamici led cancer biology at H3 Biomedicine and advanced splicing modulator drug development including H3B-8800 targeting the SF3B1 splicing factor mutation in myelodysplastic syndromes and chronic lymphocytic leukemia. Her work established the cancer splicing modulator field. She is a leader in spliceosome-targeted drug discovery.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Silvia Buonamici 的研究动态
Follow Silvia Buonamici's research updates
留下邮箱，当我们发布与 Silvia Buonamici（H3 Biomedicine (Eisai)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment